These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8928344

  • 1. [Proscar (finasteride, MSD) in the treatment of patients with prostatic hyperplasia].
    Pytel' IuA, Vinarov AZ.
    Urol Nefrol (Mosk); 1996; (4):25-7. PubMed ID: 8928344
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu, Kosko DV, Loran OB, Kan IaD, Sapozhnikov IM, Tevlin KP.
    Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Benign prostatic hyperplasia--its treatment with Proscar].
    Panchev P, Neĭkov K, Simeonov P.
    Khirurgiia (Sofiia); 1996; 49(1):15-8. PubMed ID: 8975081
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
    Kearney MC, Bingham J, Bergland R, Meade-D'Alisera P, Puchner PJ.
    J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
    Magoha GA.
    East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
    [Abstract] [Full Text] [Related]

  • 13. Finasteride in benign prostatic hyperplasia.
    Wysowski DK, Farinas E.
    N Engl J Med; 2004 Mar 25; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct 31; 144(44):56. PubMed ID: 12494605
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ, Miner M.
    Clin Ther; 2007 Jan 31; 29(1):17-25. PubMed ID: 17379044
    [Abstract] [Full Text] [Related]

  • 18. [Combined use of 5 alpha-reductase inhibitors and alpha-l adrenergic receptor blockers in patients with benign prostatic hyperplasia].
    Tkachuk VN, Al'-Shukri SKh, Luk'ianov AE, Kornienko VI, Kuz'min IV.
    Urol Nefrol (Mosk); 1998 Jan 31; (3):5-8. PubMed ID: 9644979
    [Abstract] [Full Text] [Related]

  • 19. [Finasteride (Proscar) for benign prostatic hypertrophy].
    Matzkin H, Chen J, Braf Z.
    Harefuah; 1993 Dec 15; 125(12):453-6, 496. PubMed ID: 7509305
    [Abstract] [Full Text] [Related]

  • 20. Finasteride in benign prostatic hyperplasia.
    Verhamme KM, Bosch RJ, Sturkenboom MC.
    N Engl J Med; 2004 Mar 25; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.